| Product Name | Varlitinib - API |
| Product Code | DA-V073-a |
| Chemical name | Varlitinib |
| Synonyms | N4-[3-Chloro-4-(2-thiazolylmethoxy)phenyl]-N6-[(4R)-4,5-dihydro-4-methyl-2-oxazolyl]-4,6-quinazolinediamine; (R)-4-[[3-Chloro-4-[(thiazol-2-yl)methoxy]phenyl]amino]-6-[(4-methyl-4,5-dihydrooxazol-2-yl)amino]quinazoline; |
| Impurity | NA |
| CAS Number | 845272-21-1 |
| Alternate CAS # | NA |
| Molecular form | C22H19ClN6O2S |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 466.94 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals |
| Boiling Point | NA |
| Applications | Varlitinib is a tyrosine kinase inhibitor being developed for the treatment of cancer. Varlitinib acts by disrupting the receptor tyrosine kinases ErbB-2, ErbB-4 and EGFR. |
| Dangerous Goods Info | NA |
| References | |
| Extra Notes | |
| Documents (MSDS) | No Data Available |
| Keywords |
